Additionally, GH treatment in GHD patients has also been found to lead to the normalization of high arterial wall thickness and arterial stiffness in these patients [5], and it normalizes a series of markers of endothelial dysfunction that are generally increased in untreated GHD patients [15]. The gene discussed is GH1; the disease is endothelial dysfunction.